Yield estimation is a key point theme for precision agriculture, especially for small fruits and in-field scenarios. This paper focuses on the metrological validation of a novel deep-learning model that robustly estimates both the number and the radii of grape berries in vineyards using color images, allowing the computation of the visible (and total) volume of grape clusters, which is necessary to reach the ultimate goal of estimating yield production. The proposed algorithm is validated by analyzing its performance on a custom dataset.
View Article and Find Full Text PDFThe olive oil industry recently introduced a novel multi-phase decanter with the "Leopard DMF" series, which gives a by-product called pâté, made up of pulp and olive wastewater with a high content of phenolic substances and without pits. This study aims to create a new culture medium, the Olive Juice Broth (OJB), from DMF pâté, and apply it to select bacteria strains able to survive and degrade the bitter substances normally present in the olive fruit. Thirty-five different bacterial strains of from the CREA-IT.
View Article and Find Full Text PDFThe incidence of colorectal cancer (CRC) is increasing, and currently it is the third most common cancer. Early CRC diagnosis is still difficult and relies on an invasive colonoscopy and tissue biopsy. The globally observed tendency demands non-invasive, specific, and accurate diagnostic tools for early diagnosis and prognosis.
View Article and Find Full Text PDFThis research was performed on marketed table olives. We investigated possible correlations among textural parameters obtained using both sensory assessment and instrumental textural analysis. The purpose of this research study was to find out any possible correlation between the two different analysis methods, especially in relation to acoustic compression.
View Article and Find Full Text PDFArch Proteom Bioinform
January 2021
Biomarkers are known to be the key driver behind targeted cancer therapies by either stratifying the patients into risk categories or identifying patient subgroups most likely to benefit. However, the ability of a biomarker to stratify patients relies heavily on the type of clinical endpoint data being collected. Of particular interest is the scenario when the biomarker involved is a continuous one where the challenge is often to identify cut-offs or thresholds that would stratify the population according to the level of clinical outcome or treatment benefit.
View Article and Find Full Text PDF